Nwam LLC Laboratory Corp Of America Holdings Transaction History

Nwam LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$259.82 - $298.18 $1.8 Million - $2.06 Million	-6,919 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$271.6 - $314.21 $21,728 - $25,136	80 Added 1.17%	6,919 $2.17 Million
Q3 2021 Nov 03, 2021	BUY	$274.82 - $308.34 $1,374 - $1,541	5 Added 0.07%	6,839 $1.93 Million
Q2 2021 Aug 04, 2021	SELL	$251.87 - $278.14 $40,299 - $44,502	-160 Reduced 2.29%	6,834 $1.89 Million
Q1 2021 Apr 23, 2021	BUY	$204.88 - $255.03 $656,640 - $817,371	3,205 Added 84.59%	6,994 $1.78 Million
Q4 2020 Jan 22, 2021	BUY	$186.91 - $214.42 $708,201 - $812,437	3,789 New	3,789 $771,000
Q3 2020 Oct 16, 2020	SELL	$167.03 - $201.3 $632,876 - $762,725	-3,789 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$113.31 - $182.44 $246,449 - $396,807	2,175 Added 134.76%	3,789 $629,000
Q1 2020 Apr 16, 2020	BUY	$104.32 - $195.28 $168,372 - $315,181	1,614 New	1,614 $204,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

Stay updated on Nwam LLC with notifications on news.